HR Versus RFA for Early Stage HCC

Clinical trial NCT02169765 · UNKNOWN

Trial details

NCT number: NCT02169765
Sponsor: Guangxi Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Liver Cancer

Start date: 2020-08-01
Primary completion: 2022-12-20
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.